SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $211.19 million. The enterprise value is $160.99 million.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 66.83 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | 66.83M |
| Shares Outstanding | 66.83M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 6.53% |
| Owned by Institutions (%) | 27.01% |
| Float | 52.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| Forward PS | 2.81 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 3.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.71, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.71 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.80 |
Financial Efficiency
Return on equity (ROE) is -50.41% and return on invested capital (ROIC) is -28.06%.
| Return on Equity (ROE) | -50.41% |
| Return on Assets (ROA) | -23.02% |
| Return on Invested Capital (ROIC) | -28.06% |
| Return on Capital Employed (ROCE) | -51.80% |
| Revenue Per Employee | $154,073 |
| Profits Per Employee | -$147,738 |
| Employee Count | 423 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 3.44 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $1.22 million in taxes.
| Income Tax | 1.22M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.04% in the last 52 weeks. The beta is 1.02, so SOPHiA GENETICS's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -38.04% |
| 50-Day Moving Average | 3.29 |
| 200-Day Moving Average | 3.57 |
| Relative Strength Index (RSI) | 54.16 |
| Average Volume (20 Days) | 33,501 |
Short Selling Information
The latest short interest is 50,494, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 50,494 |
| Short Previous Month | 48,452 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 1.26 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $65.17 million and -$62.49 million in losses. Loss per share was -$0.95.
| Revenue | 65.17M |
| Gross Profit | 43.94M |
| Operating Income | -66.57M |
| Pretax Income | -66.00M |
| Net Income | -62.49M |
| EBITDA | -64.63M |
| EBIT | -66.57M |
| Loss Per Share | -$0.95 |
Full Income StatementBalance Sheet
The company has $80.23 million in cash and $30.03 million in debt, giving a net cash position of $50.20 million or $0.75 per share.
| Cash & Cash Equivalents | 80.23M |
| Total Debt | 30.03M |
| Net Cash | 50.20M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 96.49M |
| Book Value Per Share | 1.45 |
| Working Capital | 72.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$42.82 million and capital expenditures -$244,000, giving a free cash flow of -$43.07 million.
| Operating Cash Flow | -42.82M |
| Capital Expenditures | -244,000 |
| Free Cash Flow | -43.07M |
| FCF Per Share | -$0.64 |
Full Cash Flow StatementMargins
Gross margin is 67.42%, with operating and profit margins of -102.14% and -95.89%.
| Gross Margin | 67.42% |
| Operating Margin | -102.14% |
| Pretax Margin | -94.01% |
| Profit Margin | -95.89% |
| EBITDA Margin | -99.17% |
| EBIT Margin | -102.14% |
| FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | -2.03% |
| Earnings Yield | -29.59% |
| FCF Yield | -20.39% |
Analyst Forecast
The average price target for SOPHiA GENETICS is $6.50, which is 107.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 107.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 25.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -1.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.53 |
| Piotroski F-Score | 2 |